THE EFFECT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA AGONIST ON ACTIVATED INFLAMMASOME IN MODELS OF NONALCOHOLIC FATTY LIVER DISEASE

被引:0
|
作者
Lee, H. J. [1 ]
Yeon, J. E. [1 ]
Ko, E. J. [1 ]
Yoon, E. L. [1 ]
Suh, S. J. [1 ]
Kang, K. [1 ]
Kim, H. R. [1 ]
Kang, S. H. [1 ]
Yoo, Y. J. [1 ]
Je, J. [1 ]
Kim, J. H. [1 ]
Seo, Y. S. [1 ]
Yim, H. J. [1 ]
Um, S. H. [1 ]
Byun, K. S. [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea
关键词
D O I
10.1016/S0168-8278(14)60418-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P256
引用
收藏
页码:S150 / S150
页数:1
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
    Hyun Jung Lee
    Jong Eun Yeon
    Eun Jung Ko
    Eileen L Yoon
    Sang Jun Suh
    Keunhee Kang
    Hae Rim Kim
    Seoung Hee Kang
    Yang Jae Yoo
    Jihye Je
    Beom Jae Lee
    Ji Hoon Kim
    Yeon Seok Seo
    Hyung Joon Yim
    Kwan Soo Byun
    World Journal of Gastroenterology, 2015, (45) : 12787 - 12799
  • [2] Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
    Lee, Hyun Jung
    Yeon, Jong Eun
    Ko, Eun Jung
    Yoon, Eileen L.
    Suh, Sang Jun
    Kang, Keunhee
    Kim, Hae Rim
    Kang, Seoung Hee
    Yoo, Yang Jae
    Je, Jihye
    Lee, Beom Jae
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Byun, Kwan Soo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (45) : 12787 - 12799
  • [3] Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
    Zarei, Mohammad
    Aguilar-Recarte, David
    Palomer, Xavier
    Vazquez-Carrera, Manuel
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 114
  • [4] The effect of peroxisome proliferator-activated receptor-delta activator on fatty acid-induced inflammasome in human liver carcinoma cell line
    Lee, Hyun Jung
    Yeon, Jong Eun
    Yoon, Eileen L.
    Suh, Sang Jun
    Kang, Keun-hee
    Kim, Hae Rim
    Kang, Seong Hee
    Yoo, Yang Jae
    Je, Ji Hye
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Um, Soon Ho
    Byun, Kwan Soo
    HEPATOLOGY, 2013, 58 : 561A - 562A
  • [5] Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease
    Choudhary, Narendra S.
    Kumar, Naveen
    Duseja, Ajay
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (06) : 731 - 739
  • [6] Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
    Wang, Nan
    Kong, Rui
    Luo, Hui
    Xu, Xiaorong
    Lu, Jie
    PPAR RESEARCH, 2017, 2017
  • [7] Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Staels, Bart
    Rubenstrunk, Anne
    Noel, Benoit
    Rigou, Geraldine
    Delataille, Philippe
    Millatt, Lesley J.
    Baron, Morgane
    Lucas, Anthony
    Tailleux, Anne
    Hum, Dean W.
    Ratziu, Vlad
    Cariou, Bertrand
    Hanf, Remy
    HEPATOLOGY, 2013, 58 (06) : 1941 - 1952
  • [8] Peroxisome proliferator-activated receptor delta and liver diseases
    Yamazaki, Tomoo
    Cable, Edward E.
    Schnabl, Bernd
    HEPATOLOGY COMMUNICATIONS, 2025, 9 (02)
  • [9] Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease
    Giby, Vettickattuparambil George
    Ajith, Thekkuttuparambil Ananthanarayanan
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (08) : 570 - 579
  • [10] Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease
    Vettickattuparambil George Giby
    Thekkuttuparambil Ananthanarayanan Ajith
    World Journal of Hepatology, 2014, (08) : 570 - 579